Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen's drug meets main goal in late-stage study for rare disease
Reuters
Wed, 06/5/24 - 11:03 am
Tags:
Amgen, clinical trials, Uplinza, IgG4-RD
ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear
Fierce Pharma
Sun, 06/2/24 - 02:51 pm
Tags:
ASCO 2024, Bristol Myers Squibb, Amgen, KRAS inhibitors, Krazati, non-small cell lung cancer
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Tags:
Amgen, AstraZeneca, biosimilars, Soliris, Bkemv
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Tags:
Amgen, AstraZeneca, COPD, Sanofi, Regeneron, Tezspire, Dupixent
In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1
Fierce Pharma
Thu, 05/16/24 - 09:51 pm
Tags:
Big Pharma, Eli Lilly, Novo Nordisk, earnings, Amgen
FDA approves Amgen drug for small cell lung cancer
Reuters
Thu, 05/16/24 - 09:47 pm
Tags:
Amgen, tarlatamab, FDA, small cell lung cancer
Winners and Losers in Biopharma’s Q1 2024 Earnings Season
BioSpace
Wed, 05/15/24 - 11:30 am
Tags:
earnings, Amgen, AstraZeneca, Novo Nordisk, Biogen, Bristol Myers Squibb, JNJ
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Tags:
Big Pharma, Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, JNJ, Tecvayli, Merck, Vaxneuvance, AbbVie, Qulipta, AstraZeneca, Saphnelo, Novartis, Leqvio, Roche, Genentech, Vabysmo, Amgen, Evenity, Pfizer, Vyndaqel
Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Tags:
Amgen, Horizon Pharma, Krystexxa, Tepezza
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters
Thu, 05/2/24 - 10:19 pm
Tags:
Amgen, clinical trials, obesity, AMG786, MariTide
Amgen’s profit slides, revenue jumps in Q1
Medical Marketing and Media
Thu, 05/2/24 - 10:09 pm
Tags:
Amgen, earnings
Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024
BioSpace
Wed, 05/1/24 - 09:31 am
Tags:
Amgen, Tezspire, COPD, AMG104, severe asthma, Tavneos, vasculitits, R&D, ATS
Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?
Fierce Pharma
Thu, 04/18/24 - 10:21 pm
Tags:
Amgen, Pharma CEOs, Bob Bradway, executive compensation
Amgen, facing potential Enbrel price cap in Colorado, takes state's new drug affordability board to court
Fierce Pharma
Tue, 03/26/24 - 04:31 pm
Tags:
Amgen, Enbrel, Medicare, Colorado, drug pricing
Acelyrin adds proof-of-concept TED data to recent readout pile, cementing challenge to Amgen
Fierce Biotech
Wed, 03/20/24 - 11:50 am
Tags:
Acellyrin, thyroid eye disease, clinical trials, lonigutamab, Amgen
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Tags:
Sandoz, biosimilars, FDA, Amgen, denosumab, Prolia, Jubbonti, Xgeva, Wyost
Amgen boots up Ohio 'smart facility' where it plans to hire 400
Fierce Pharma
Mon, 02/26/24 - 11:13 am
Tags:
Amgen, Ohio, drug manufacturing, hirings
Amgen details rare disease ambitions following $28B Horizon acquisition
Medical Marketing and Media
Sun, 02/25/24 - 09:04 pm
Tags:
Amgen, Horizon Therapeutics, rare disease, M&A
Colorado could cap payments for Amgen’s Enbrel
Stat
Thu, 02/22/24 - 11:47 am
Tags:
Colorado, Amgen, autoimmune disease, Enbrel, reimbursement
Innovent's Tepezza rival one step closer to Chinese approval after phase 3 eye disease win
Fierce Biotech
Tue, 02/20/24 - 05:51 pm
Tags:
Innovent Biologics, thyroid eye disease, Tepezza, China, Amgen, IBI311

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.